Lindian Resources Ltd (ASX:LIN, OTC:LINIF) has awarded all major non-process infrastructure (NPI) contracts for its Kangankunde Rare Earths Project in Malawi, with construction now progressing across multiple work packages. All NPI scopes fall within the capital parameters of the Stage 1 feasibility study and are integrated into the broader project execution plan alongside early works and mobilisation of the owner-operator mining fleet.
All major NPI contracts awarded, covering the:
American Resources Corp (NASDAQ:AREC) announced that its minority-owned subsidiary, ReElement Technologies, has filed five new patent applications aimed at strengthening US refining capabilities for several high-priority critical and rare earth elements.
The filings expand ReElement’s intellectual property portfolio and support domestic processing of materials such as germanium, antimony, terbium, gallium, gadolinium and yttrium, minerals widely used in advanced manufacturing, energy technologies and defense applications, the company said on Wednesday.
Aftermath Silver Ltd (TSX-V:AAG, OTCQX:AAGFF) announced that it has begun a new phase of drilling at its Berenguela silver-copper-manganese project in southern Peru and has also commenced drilling at its Challacollo silver-gold project in northern Chile.
The company said the Berenguela program includes 4,000 metres of diamond drilling and 2,000 metres of reverse-circulation drilling.
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) said on Wednesday that its organic TerraSante biofertility product delivered substantial improvements in potato yields, size and quality in commercial farming trials in Washington State and Idaho, adding to evidence that the mustard-derived input could boost returns for growers.
A Washington State farmer using TerraSante at 11 pounds per acre on a large commercial field reported an estimated increase of about US$5,000 in value per acre, compared with a cost of roughly US$180 per acre for the biofertilizer, the company said.
HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) announced that it produced 290 Bitcoin in November, marking a year-to-date monthly high and a 182% increase from the same month in 2024.
The company said average daily production was 9.7 BTC, with hashrate averaging 23.5 exahash per second (EH/s) and peaking at 25.4 EH/s. Fleet efficiency was 17.5 joules per terahash.
Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF) said that TotalEnergies will take over as operator of Namibia’s PEL 83 and acquire a 40% stake in the exploration block under a new agreement with Galp Energia, adding fresh momentum to activity in the country’s prolific Orange Basin.
Galp, which currently operates the licence and holds an 80% interest, announced the deal on its corporate website. Namibia’s NAMCOR holds 10% of the block, while Custos Energy, partly owned by Canada-listed Sintana, retains another 10%.
CRISM Therapeutics shares fell 12% to 6.93p after the clinical-stage oncology company unveiled a £1 million fundraise at a steep discount to support its phase II trial in glioblastoma.
The placing, handled by SP Angel, saw the company issue 11.1 million new shares at 9p each, about 18% below Friday’s close.
Futura Medical PLC (AIM:FUM, OTC:FAMDF) has secured patent protection in China for its erectile dysfunction gel Eroxon, a move the company says should strengthen its hand as it looks for commercial partners in one of the world’s largest markets.
The notice of allowance means the patent, once formally granted, will run until 2040.
Volt Resources Ltd (ASX:VRC, OTC:VLTRF) has signed a Binding Term Sheet with Unbounded Opportunities Fund SPC (UOF) for a conditional US$11.1 million equity investment and joint project development of its Bunyu Graphite Project in Tanzania — a move that brings a new funding pathway and revised project parameters into focus.
The agreement sets out a framework for UOF to support a redesigned Stage 1 development targeting higher production rates, improved capital efficiency and lower unit operating costs than outlined in Volt’s 2023 feasibility update.
Orthocell Ltd (ASX:OCC, OTC:ORHHF) has achieved its first commercial sales of Remplir™ in Hong Kong, marking a meaningful step in the company’s push into Asia and rounding out a strong year of geographic expansion for its flagship nerve repair device.
The initial sales to in-country distributor MontsMed follow last month’s first surgical use of Remplir in Hong Kong and a well-received debut at the Hong Kong Orthopaedic Association’s 45th Annual Congress — momentum the company expects will translate into a growing base of surgeon adopters.
Terrain Minerals Ltd (ASX:TMX, OTC:TMXAF) has strengthened its balance sheet ahead of a pivotal exploration year, completing a $1.422 million placement that ensures full funding for drilling across its Lightning, Wildflower and wider Smokebush prospects.
The raise — priced at $0.004 per share and strongly backed by existing shareholders and the board — brings Terrain’s combined October and December capital raisings to $2.75 million.
Lindian Resources Ltd (ASX:LIN, OTC:LINIF) has moved to full ownership of the Kangankunde Rare Earths Project in Malawi after paying the final US$10 million tranche under its Share Sale Agreement to acquire Rift Valley Resource Developments Limited (RVRD).
The payment increases Lindian’s stake in RVRD from 67% to 100%, delivering full legal and beneficial ownership of the Malawian company and giving Lindian 100% direct control of Kangankunde, described as one of the world’s largest and highest-grade rare earth deposits currently under development.
European Lithium Ltd (ASX:EUR, OTCQB:EULIF)'s 100% owned subsidiary Critical Metals Corp (Nasdaq: CRML) has executed a term sheet to establish a 50:50 joint venture with Fabrica de Prelucrare a Concentratelor de Uraniu S.R.L. (FPCU) of Romania.
FPCU is a Romanian state-owned entity and strategic partner from a European Union and NATO member country. The JV will secure 50% of the offtake from the Tanbreez rare earth element (REE) concentrate, increasing total contracted offtake from the Tanbreez Project to 75% of future production.